ClinicalTrials.Veeva

Menu

Non-Interventional Study With LYRICA (Pregabalin) In Patients With Epilepsy As Adjunctive Therapy Of Partial Seizures To Reduce Seizure Frequency

Viatris logo

Viatris

Status

Completed

Conditions

Epilepsy

Treatments

Other: Non-Interventional Study

Study type

Observational

Funder types

Industry

Identifiers

NCT00684424
A0081213

Details and patient eligibility

About

The primary efficacy parameter will be the responder rate, defined as the proportion of subjects who had at least a 50% reduction in 28 day seizure rate during the maintenance phase

Enrollment

199 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age over 18 years old, patients with epilepsia with partial seizures
  • Enrollment to study is fully on physician decision in compliance with current SPC.

Exclusion criteria

  • Patient who did not meet indication according to SPC Lyrica

Trial design

199 participants in 1 patient group

Outpatients with epilepsy
Treatment:
Other: Non-Interventional Study

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems